Attorneys: PDMA isn't broken, don't change it

Share this article:

Two Hyman, Phelps & McNamara attorneys have told the US Sentencing Commission that the guideline for misdemeanor offenses under the Prescription Drug Marketing Act isn't broken and shouldn't be changed. The FDA asked the commission to consider changing the guideline because its maximum prison term isn't enough.

Share this article:

Email Newsletters

More in Business Briefs

Social media perceived as clinical trial risk

The Wall Street Journal reports that patients are sharing a plethora of information about their clinical trial experiences, from how to get picked, to how to figure out who is in a control group.

Cancer PSA features scientists

Stand Up To Cancer is kicking off a PSA that features Grammy-winner Jennifer Hudson and a Genentech scientist.

Lawmakers eye pricing

The Senate Judiciary Committee's antitrust panel is looking into how three major pharmaceutical manufacturers decided to set minimum prices for their contact lenses.